Related Experiment Video
Updated: Aug 26, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2
Chun Shik Park1, Sung Il Kim, Mi Su Lee
1Department of Life Science, Kwangju Institute of Science and Technology, 1 Oryong-dong, Puk-gu, Kwangju 500-712, Korea.
Abstract:
beta-Catenin functions as a downstream component of the Wnt/Wingless signal transduction pathway, and inappropriate control of cytosolic beta-catenin is a crucial step in the genesis of several human cancers. Here we demonstrate that cyclin-dependent kinase 2 (CDK2) in association with cyclin A or cyclin E directly binds to beta-catenin. In vivo and in vitro kinase assays with cyclin-CDK2 demonstrate beta-catenin phosphorylation on residues Ser(33), Ser(37), Thr(41), and Ser(45). This phosphorylation promotes rapid degradation of cytosolic beta-catenin via the beta-TrCP-mediated proteasome pathway. Moreover, cyclin E-CDK2 contributes to rapid degradation of cytosolic beta-catenin levels during G(1) phase by regulating beta-catenin phosphorylation and subsequent degradation. In this way, CDK2 may "fine tune" beta-catenin levels over the course of the cell cycle.
Insights
Cyclin-dependent kinase 2 (CDK2) directly binds and phosphorylates beta-catenin, promoting its degradation. This mechanism fine-tunes beta-catenin levels during the cell cycle, impacting cancer development.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- Beta-catenin is a key downstream component of the Wnt/Wingless signaling pathway.
- Dysregulation of cytosolic beta-catenin is implicated in the development of various human cancers.
Purpose of the Study:
- To investigate the interaction between cyclin-dependent kinase 2 (CDK2) and beta-catenin.
- To elucidate the role of CDK2 in regulating beta-catenin phosphorylation and degradation.
Main Methods:
- In vivo and in vitro kinase assays were performed.
- Analysis of beta-catenin phosphorylation at specific residues (Ser33, Ser37, Thr41, Ser45).
- Investigation of the beta-TrCP-mediated proteasome degradation pathway.
Main Results:
- CDK2, in complex with cyclin A or cyclin E, directly binds to beta-catenin.
- Cyclin-CDK2 phosphorylates beta-catenin on specific serine and threonine residues.
- Phosphorylation by cyclin E-CDK2 leads to rapid degradation of cytosolic beta-catenin via the proteasome pathway during the G1 phase.
Conclusions:
- CDK2 plays a critical role in regulating beta-catenin stability through phosphorylation and subsequent degradation.
- This regulatory mechanism fine-tunes cytosolic beta-catenin levels throughout the cell cycle.
- Understanding this pathway offers potential insights into cancer development and therapeutic strategies.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Positive Regulator Molecules
Positive Regulator Molecules
MAPK Signaling Cascades
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anaphase Promoting Complex

